Our findings suggest that vitamin B12 may be a potential therapeutic target for TDP-43-associated proteinopathies, and oral intake of Hb may be a potential therapeutic intervention for TDP-43-related ALS. Here, TARDBP is linked to proteostasis deficiencies.